Literature DB >> 8023740

Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofenac.

A Conforti1, M Donini, G Brocco, P Del Soldato, G Benoni, L Cuzzolin.   

Abstract

Diclofenac and its derivative nitrofenac were compared to test their anti-inflammatory efficacy and gastrointestinal toxicity in rats. A similar good anti-inflammatory activity of the two drugs was observed in carrageenan oedema and a marked gastrointestinal toxicity was induced by diclofenac, while nitrofenac failed to produce gastric damage even with very high doses (50 and 100 mg/kg). The lack of the gastric ulcers in rats treated with nitrofenac could be due to the absorption of the drug as an inactive inhibitor of PG synthesis and/or to the fact that probably nitric oxide is released in the intestine and plays an important protective role in maintaining the tissue integrity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8023740     DOI: 10.1007/bf01984058

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Concerning the merits of copper aspirin as a potential anti-inflammatory drug.

Authors:  K D Rainsford; M W Whitehouse
Journal:  J Pharm Pharmacol       Date:  1976-01       Impact factor: 3.765

Review 2.  The biochemical pathology of aspirin-induced gastric damage.

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1975-10

Review 3.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

Review 4.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 5.  Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract.

Authors:  D S Rampton
Journal:  Scand J Gastroenterol       Date:  1987-01       Impact factor: 2.423

6.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

7.  The pharmacology of diclofenac sodium (Voltarol).

Authors:  R Maier; R Menassé; L Riesterer; C Pericin; M Ruegg; R Ziel
Journal:  Rheumatol Rehabil       Date:  1979

8.  Isolation and washing of human platelets with nitric oxide.

Authors:  M W Radomski; R M Palmer; N G Read; S Moncada
Journal:  Thromb Res       Date:  1988-05-15       Impact factor: 3.944

9.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

10.  Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity.

Authors:  K D Rainsford; M W Whitehouse
Journal:  Agents Actions       Date:  1980-11
  10 in total
  5 in total

1.  Licorice: a possible anti-inflammatory and anti-ulcer drug.

Authors:  Adel M Aly; Laith Al-Alousi; Hatem A Salem
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

2.  Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells.

Authors:  R Korhonen; R Korpela; M Saxelin; M Mäki; H Kankaanranta; E Moilanen
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

Review 3.  Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors:  J E Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

4.  Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis.

Authors:  E Martín-Mola; J Gijón-Baños; J J Ansoleaga
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

5.  Cytoprotection and healing: two unequal brethren.

Authors:  F Halter; B Peskar; K D Rainsford; A Schmassmann
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.